What skin biopsy is indicated for a forehead lesion that has enlarged despite treatment for seborrheic dermatitis and oral terbinafine, to rule out skin cancer or other dermatoses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Perform an Excisional Biopsy to Rule Out Skin Cancer

For a forehead lesion that has enlarged despite treatment for seborrheic dermatitis and oral terbinafine, you should perform a complete excisional biopsy with 1-3 mm margins extending to the deep reticular dermis. This is the definitive diagnostic approach when malignancy cannot be excluded clinically.

Clinical Reasoning

The clinical scenario raises significant concern for malignancy:

  • Treatment failure is a red flag: The lesion was initially treated as seborrheic dermatitis without improvement, then inappropriately given oral terbinafine (which is indicated only for onychomycosis, not facial dermatoses) 1
  • Progressive enlargement: Any growing facial lesion despite treatment warrants tissue diagnosis to exclude basal cell carcinoma, squamous cell carcinoma, or melanoma
  • Facial location: The forehead is a common site for skin cancers, particularly in sun-exposed individuals

Recommended Biopsy Technique

Excisional biopsy is strongly preferred over incisional/partial biopsy for the following critical reasons 2:

  • Prevents misdiagnosis: Partial sampling risks missing the most aggressive area of a potential melanoma
  • Enables complete histologic assessment: Full examination is necessary to determine maximum tumor thickness (Breslow depth), which directly impacts staging and treatment decisions
  • Avoids repeat procedures: If benign, no further treatment needed; if malignant, proper margins and depth are already documented

Technical Approach

Perform the excisional biopsy using one of these methods 3, 4:

  1. Elliptical (fusiform) excision - preferred for most lesions
  2. Punch excision around the entire clinical lesion
  3. Deep shave/saucerization extending into the deep reticular dermis

Critical technical points 2:

  • Use 1-3 mm peripheral margins around the concerning lesion
  • Extend depth to avoid transecting the lesion at the deep margin
  • Use a scalpel (never laser or electrocautery, which destroys tissue architecture)
  • Orient the incision parallel to skin tension lines for optimal re-excision if needed
  • Take pre-biopsy photographs including anatomic landmarks

Essential Pathology Information

Provide the pathologist with 2:

  • Patient age and sex
  • Exact anatomic site (forehead)
  • Clinical history: "enlarging lesion, failed treatment for seborrheic dermatitis"
  • Clinical differential diagnosis: rule out skin cancer vs. inflammatory dermatosis

Common Pitfalls to Avoid

  1. Do NOT perform a superficial shave biopsy - this may transect a melanoma and prevent accurate Breslow depth measurement
  2. Do NOT use punch biopsy for sampling only - partial biopsies of melanocytic lesions risk sampling error
  3. Do NOT delay biopsy - any treatment-resistant, enlarging facial lesion requires tissue diagnosis
  4. Do NOT assume seborrheic dermatitis - while common on the face 5, 6, it should respond to appropriate topical therapy; failure to respond mandates biopsy

Why Not Incisional Biopsy?

While facial dermatoses have a more limited differential diagnosis than other body sites 7, the history of progressive enlargement despite treatment makes complete excision mandatory. Incisional biopsy would only be acceptable if the lesion is too large for complete excision in a single procedure, which is rarely the case on the forehead.

References

Guideline

cutaneous melanoma.

British Journal of Cancer, 2001

Guideline

guidelines of care for the management of primary cutaneous melanoma.

Journal of the American Academy of Dermatology, 2019

Guideline

nccn guidelines® insights: melanoma: cutaneous, version 2.2021.

Journal of the National Comprehensive Cancer Network : JNCCN, 2021

Research

Current Understanding of Seborrheic Dermatitis: Treatment Options.

Journal of cutaneous medicine and surgery, 2025

Research

Seborrheic Dermatitis: Diagnosis and Treatment.

American family physician, 2025

Research

Biopsies of facial dermatoses made simple.

Archives of pathology & laboratory medicine, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.